Privacy Policy :: Mircette

Duramed Pharmaceuticals, Inc. ("Duramed") respects your privacy, and the privacy of all visitors to its Web sites (the "Sites"). It's the company's policy to collect only personally identifiable information, such as names, addresses, telephone/fax numbers, or e-mail addresses, when such information is voluntarily submitted by our visitors. This information will be kept strictly confidential and will not be sold, reused, rented, loaned or otherwise disclosed, except as described in this privacy policy.

We will not disclose your information, other than to our contractors where necessary, to operate and maintain this Web site or as required by law or legal process.

We will only use the information we collect from you to answer any of your requests for information, such as to send you updates or other informational mailings you may find useful or to better understand your needs.

Tracking Technology ("Cookies")
Cookies are small text files that are sent by a Web site, accepted by a Web browser and then placed on your hard drive. Duramed Web sites may use cookies to collect data that help provide information regarding the functionality of the site or to help analyze browsing patterns and use of the site.

Children
The Sites are not intended or designed to attract children under the age of 13. Duramed does not collect personally identifiable data from any person we know to be under the age of 13.

Revisions to this Policy
Duramed reserves the right, at our discretion, to change, modify, add, or remove portions of this Policy at any time. If we change our Privacy Policy, we will post those changes on this page so that you may become aware of what information we may collect, how we may use it and under what circumstances we may disclose it. You should visit this page from time to time to review the then-current policy because it's binding on you. This Privacy Policy was last updated on June 2003.

General
Links from these Sites may take you to sites not covered by this Privacy Policy, and we advise you to check the applicable privacy practices yourself.

Each package contains 21 tablets of 0.15 mg desogestrel and 20 mcg ethinyl estradiol (EE), 2 placebo tablets, and 5 tablets of 10 mcg EE.

Mircette^® tablets are indicated for the prevention of pregnancy.

Serious as well as minor side effects can occur with oral contraceptives. Serious risks include myocardial infarction, thromboembolism, stroke, hepatic neoplasia and gallbladder disease. Cigarette smoking increases the risk of serious cardiovascular side effects; women who take oral contraceptives are strongly advised not to smoke. The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, obesity and diabetes. Oral contraceptives do not protect against HIV infection (AIDS) and other sexually transmitted infections.

© 2007 Duramed Pharmaceuticals, Inc. All rights reserved.

Mircette^® and Duramed^® are registered trademarks of Duramed Pharmaceuticals, Inc.
Duramed is a subsidiary of Barr Pharmaceuticals, Inc.
The site is intended for residents of the United States only.